Ipilimumab and radiation therapy for melanoma brain metastases

by Silk, Ann W, Bassetti, Michael F, West, Brady T, Tsien, Christina I, Lao, Christopher D
Published 2013

Metastatic Merkel cell carcinoma response to nivolumab

by Walocko, Frances M., Scheier, Benjamin Y., Harms, Paul W., Fecher, Leslie A., Lao, Christopher D.
Published 2016

IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation

by Eto, Danelle, Lao, Christopher, DiToro, Daniel, Barnett, Burton, Escobar, Tania C., Kageyama, Robin, Yusuf, Isharat, Crotty, Shane
Published 2011

Dose escalation of a curcuminoid formulation

by Lao, Christopher D, Ruffin, Mack T, Normolle, Daniel, Heath, Dennis D, Murray, Sandra I, Bailey, Joanne M, Boggs, Martha E, Crowell, James, Rock, Cheryl L, Brenner, Dean E
Published 2006

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

by Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Published 2012

Concurrent whole brain radiotherapy and bortezomib for brain metastasis

by Lao, Christopher D, Friedman, Judah, Tsien, Christina I, Normolle, Daniel P, Chapman, Christopher, Cao, Yue, Lee, Oliver, Schipper, Matt, Van Poznak, Catherine, Hamstra, Daniel, Lawrence, Theodore, Hayman, James, Redman, Bruce G
Published 2013

A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01...

by Clark, Joseph, Flaherty, Lawrence, Ernstoff, Marc, Koon, Henry, Milhem, Mohammed, Militello, Gerald, Agarwala, Sanjiv, Curti, Brendan, Cranmer, Lee, Lao, Christopher D, Logan, Theodore F, Lutzky, Jose, Rudrapatna, Venkatesh, Daniels, Gregory, Taback, Bret, Aung, Sandra, Lowder, James, Lawson, David
Published 2014

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial12: A TITE-CRM Phase I/II Clinical Trial

by Kim, Michelle M., Parmar, Hemant, Cao, Yue, Pramanik, Priyanka, Schipper, Matthew, Hayman, James, Junck, Larry, Mammoser, Aaron, Heth, Jason, Carter, Corey A., Oronsky, Arnold, Knox, Susan J., Caroen, Scott, Oronsky, Bryan, Scicinski, Jan, Lawrence, Theodore S., Lao, Christopher D.
Published 2016